<?xml version='1.0' encoding='iso-8859-1' ?>
<documents><document>
<title>Translational and Transcriptional Inhibitors Block Serotonergic Phase Advances of the Suprachiasmatic Nucleus Circadian Pacemaker In Vitro</title>
<publication-date>2002-01-01T00:00:00-08:00</publication-date>
<state>published</state>
<authors>
<author>
<institution>University of Tennessee - Knoxville</institution>
<lname>Prosser</lname>
<fname>Rebecca</fname>
</author>
<author>
<institution>University of Tennessee - Knoxville</institution>
<lname>Jovanovska</lname>
<fname>Aneta</fname>
</author>
</authors>
<keywords>
<keyword>circadian rhythms</keyword>
<keyword>suprachiasmatic nucleus</keyword>
<keyword>serotonin</keyword>
<keyword>8-hydroxy-dipropylaminotetralin HBr</keyword>
<keyword>protein synthesis</keyword>
<keyword>anisomycin</keyword>
<keyword>cycloheximide</keyword>
<keyword>5</keyword>
<keyword>6-dichloro-1-[.beta]-ribobenzimidazole</keyword>
<keyword>rats</keyword>
</keywords>
<disciplines><discipline>Biochemistry</discipline>
<discipline>Cell Anatomy</discipline>
<discipline>Molecular Biology</discipline>
</disciplines><abstract>&lt;p&gt;The mammalian circadian pacemaker is located in the suprachiasmatic  nucleus (SCN). Various inputs modulate pacemaker phase, including  the serotonergic (5HTergic) input from the midbrain raphe. 5HT  phase-advances the SCN pacemaker when applied during mid subjective day. In vitro studies indicate that 5HT advances the mammalian circadian pacemaker through a process that includes stimulating 5HT&lt;sub&gt;7&lt;/sub&gt; receptors, activating protein kinase A, and opening K&lt;sup&gt;+&lt;/sup&gt; channels. How these cytoplasmic and membrane events translate into a shift in the molecular core of the circadian oscillator is not known. To further understand this process, the authors investigated whether 5HTergic phase advances require transcription or translation. Using two reversible translational inhibitors, anisomycin and cycloheximide, the authors show that inhibiting protein synthesis blocks 5HTergic phase shifts. The authors further show that the transcriptional inhibitor 5,6-dichloro-1-[.beta]-ribobenzimidazole also blocks 5HTergic phase shifts. These results are similar to those found previously with respect to 5HTergic modulation of the &lt;em&gt;Aplysia&lt;/em&gt;  ocular circadian clock, and suggest that 5HT may phase-shift the SCN pacemaker through increasing transcription and translation of specific proteins.&lt;/p&gt;</abstract>
<coverpage-url>https://trace.tennessee.edu/utk_biocpubs/28</coverpage-url>
<label>28</label>
<document-type>article</document-type>
<type>article</type>
<articleid>1027</articleid>
<submission-date>2010-06-11T08:16:39-07:00</submission-date>
<publication-title>Faculty Publications and Other Works -- Biochemistry, Cellular and Molecular Biology</publication-title>
<context-key>1353993</context-key>
<submission-path>utk_biocpubs/28</submission-path>
<fields>
<field name="create_openurl" type="boolean">
<value>true</value>
</field>
<field name="custom_citation" type="string">
<value>Translational and Transcriptional Inhibitors Block Serotonergic Phase Advances of the Suprachiasmatic Nucleus Circadian Pacemaker In Vitro

Jovanovska, Aneta, Prosser, Rebecca A.
J Biol Rhythms, Apr 2002; vol. 17: pp. 137-146</value>
</field>
<field name="embargo_date" type="date">
<value>2010-06-11T00:00:00-07:00</value>
</field>
<field name="publication_date" type="date">
<value>2002-01-01T00:00:00-08:00</value>
</field>
<field name="source_fulltext_url" type="string">
<value>http://jbr.sagepub.com/cgi/content/abstract/17/2/137</value>
</field>
</fields>
</document>
</documents>